The company raised its 2021 sales forecast for its coronavirus vaccine by 73%. Pfizer also lifted its annual revenue guidance -- and raised guidance excluding coronavirus vaccine sales. Investors looking for income should be happy too: Pfizer is maintaining its dividend level even after Viatris -- the result of its Upjohn spinoff -- begins paying one.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting